Delayed cord clamping and gentle surfactant for premature babies
Part of Lungs & breathing clinical trials.
This study tests whether waiting a bit longer to clamp the umbilical cord, combined with giving a natural lung coating (called surfactant) through a thin tube instead of a breathing tube, helps premature babies breathe better. It is for babies born before 30 weeks who have breathing trouble after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born between 23 weeks and 29 weeks and 6 days of pregnancy.
- Your baby must be breathing on their own right after birth.
- Your baby must have been diagnosed with respiratory distress syndrome (breathing trouble after birth).
- Your baby must not have needed a breathing tube for resuscitation or other reasons shortly after birth.
- Your baby must not have any major birth defects or severe complications like bleeding, air leaks, or early infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a natural lung coating (surfactant) early, using a thin tube rather than a breathing machine, can help very premature babies with breathing problems breathe better and avoid more serious breathing treatments.
This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.
This study tests a lung medication called pulmonary surfactant, given with different oxygen levels, to help very premature babies (born before 32 weeks) who have breathing difficulties. The goal is to see which oxygen level works best with non-invasive breathing support.
This trial looks at giving a “surfactant” medicine (a substance that helps keep baby lungs open) to newborns who have serious breathing problems soon after birth. It may help babies with neonatal respiratory distress or acute breathing distress, especially if they’re treated in the early time window.
This trial tests two ways of giving surfactant (a lung medicine) to very premature babies with respiratory distress syndrome. It may help show which method works better and is safer for helping newborn lungs breathe.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
Hear when a new NRDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.